The average selling price for ECAP in Australia dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the ECAP device in Australia can be viewed in GlobalData’s micro pricing report. Buy the report here.
Go deeper with GlobalData
The ECAP is sold by Smith & Nephew Plc in the Patella market. Knee reconstruction is a surgical procedure involving the replacement of damaged or diseased parts of the knee joint. Patella (kneecap) implants are used in primary, partial, and revision knee replacement procedures.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Smith & Nephew Plc’ Patella device pricing in Australia, buy the report here.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
